Patent: 4,791,099
✉ Email this page to a colleague
Summary for Patent: 4,791,099
Title: | Method of treatment for central nervous system diseases such as Alzheimer\'s \'s disease |
Abstract: | A method of treating humans suffering from central nervous system diseases, such as Alzheimer\'s disease, cerebral atrophy, Parkinson\'s disease, senile tremor, essential tremor, and cerebellar atrophy, as well as diseases where dementia is present. The treatment consists of inducing into the patient\'s blood stream at least one from the group consisting of: sex hormones and anabolic hormones. Ergolid myselates may be used in conjunction with the hormone, as well as a vasodilator and non-steroid anti-inflammatory. Growth hormone may also be used in those patients in advanced stages of the disease, or in those patients where it has been determined that a low level of growth hormone is present. |
Inventor(s): | Aroonsakul; Chaovanee (Chicago, IL) |
Assignee: | |
Application Number: | 06/666,254 |
Patent Claims: | see list of patent claims |
Details for Patent 4,791,099
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2040-04-01 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2040-04-01 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2040-04-01 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/16/1990 | ⤷ Try a Trial | 2040-04-01 |
Bel-mar Laboratories, Inc. | CHORIONIC GONADOTROPIN | chorionic gonadotropin | Injection | 017054 | 03/26/1974 | ⤷ Try a Trial | 2040-04-01 |
Ferring Pharmaceuticals Inc. | A.P.L. | chorionic gonadotropin | For Injection | 017055 | 12/13/1974 | ⤷ Try a Trial | 2040-04-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |